about
Smart nanosystems: Bio-inspired technologies that interact with the host environmentVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmA synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis.EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interferenceIntravenously administered nanoparticles increase survival following blast trauma.Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity.Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.Alternatives to allogeneic platelet transfusion.In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumorsShear-thinning nanocomposite hydrogels for the treatment of hemorrhage.Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.Surgical Materials: Current Challenges and Nano-enabled Solutions.Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrinSynthetic Strategies for Engineering Intravenous Hemostats.Platelet mimetic particles for targeting thrombi in flowing bloodNon-affinity factors modulating vascular targeting of nano- and microcarriersNanoparticle biointerfacing by platelet membrane cloaking.Haem-assisted dityrosine-cross-linking of fibrinogen under non-thermal plasma exposure: one important mechanism of facilitated blood coagulation.Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C.Bioengineered nanoparticles for siRNA delivery.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair.Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.Intravenous hemostats: challenges in translation to patientsHemostatic strategies for traumatic and surgical bleeding.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.Targeted Nanotherapies for the Treatment of Surgical Diseases.Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management.Halting hemorrhage with self-propelling particles and local drug delivery.A nanostructured synthetic collagen mimic for hemostasis.Acute Myeloid Leukemia: How Do We Measure Success?Hierarchical biointerfaces assembled by leukocyte-inspired particles for specifically recognizing cancer cells.Cell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds.Ultrasoft microgels displaying emergent platelet-like behaviours.Bio-inspired nanomedicine strategies for artificial blood components.Steroid-Loaded Hemostatic Nanoparticles Combat Lung Injury after Blast Trauma.Intravenous hemostatic nanoparticles increase survival following blunt trauma injury.
P2860
Q26776370-04C618D9-81E9-426B-96FD-F02E92DD4D7DQ27026630-53B9FE39-ADC7-4957-9FEA-4BD60B14A80EQ27327667-C1E14260-E665-42F8-810C-2535C5F291D4Q28486127-1442076B-D61B-4520-989A-4EECAAA2B971Q30584438-F5BF98EA-5AF1-4A50-905C-10E17B091480Q33401554-187EC4D4-ECFA-42FA-9555-C5FD7708DB53Q33402878-3211AD5A-3FF0-41C1-ABAF-E726211B44A3Q33435484-7FB7B4F1-F2FD-4AEE-A7BC-6A6F12FB4934Q33437439-7C0CB4CE-37F5-404F-9DDE-AC07C2D62446Q34379208-88520B87-1496-4C6C-9BA7-3543E8699620Q34419933-C7AE2291-DB77-4451-9A12-D3F61B46C31EQ34579964-35DB6700-9F61-434F-BBF0-587E0BA1F406Q34706866-7605BCF5-6AE2-4C5C-946C-5374D5D295E6Q35664758-6949EF72-D494-496F-BD2A-9E8F49BF8BAEQ35858739-01FCCC8B-2654-4F1B-BEE8-72886761C273Q36355586-6DCB908F-C77B-4924-A207-E31BC25F43BEQ36703526-A62F2279-449C-4063-862D-699E17828857Q36912680-703B2E50-0150-4B97-8B6B-5925E3652686Q36941506-6B21641D-C806-4303-B5CA-3BE0607ED6C2Q37278074-E0FF9F4F-F3CB-4E19-8AE6-714C7E682249Q37679156-D953BFD7-FFA4-4990-86F2-F46C6D0D70ABQ37845396-4DAF6137-F66B-4C7D-866C-4FE306179805Q37896455-E31FBE4D-9F40-4C30-9FF6-2E2F884DB439Q38010642-EDEB5CBE-9174-4380-BDF8-690DE90FB32EQ38075542-B84CC7F6-092D-4420-9EED-E1B1D9013A54Q38105137-897C26E1-66C1-4CC7-BB40-8E5E6247D840Q38148673-02D31C74-C8D5-4546-9E56-D38B2E7F3243Q38168784-61A9D0C3-ECCC-4B61-BC08-D148974503A2Q38495085-70B328E3-A75D-403B-A312-07763564BFBEQ38693341-8F821562-186B-44EC-A3AC-25B8D46007F4Q38813909-4191BC85-889E-4583-9A50-7CC614B9F1ECQ38840359-5D9DB4E2-BF1B-4FC3-B5E6-DDBF0DE14B9BQ38862626-E7D515AA-A037-4DAE-A747-A8E022049C3EQ38948650-1C2F2863-F30E-4E01-8499-1F9758FE6B5AQ38993907-D4E689F4-6BA7-471D-AAB3-390C12AE4F59Q39031369-8EDA1B68-2602-4B5D-A966-853FBD20B94AQ39133739-C8240BBC-3D9C-4787-A936-59109280C58BQ39179984-C9E9E4CF-AACF-442E-85C8-7F5DDC7C6134Q41156067-B2106288-9058-48C5-9C9B-2EB4B2EDF028Q41215308-C6FF5EEC-8F4D-45DE-89A4-F9C591F18C8B
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Intravenous hemostat: nanotechnology to halt bleeding.
@en
type
label
Intravenous hemostat: nanotechnology to halt bleeding.
@en
prefLabel
Intravenous hemostat: nanotechnology to halt bleeding.
@en
P2093
P2860
P1476
Intravenous hemostat: nanotechnology to halt bleeding
@en
P2093
Cicely A Williams
Erin B Lavik
James P Bertram
Nolan T Flynn
Rebecca Robinson
P2860
P304
P356
10.1126/SCITRANSLMED.3000397
P407
P50
P577
2009-12-01T00:00:00Z